CDH2 and prostate cancer: We examined TrampC1 and RM1 after treatment with the fibroblast-conditioned medium and found that the expression of E-cadherin was decreased in the prostate cancer epithelial cells and that the expression of N-cadherin and vimentin was increased due to the upregulation of YAP1 (Fig. 2h).